Form 4 for TARS Tarsus Pharmaceuticals, Inc.
Accepted 2023-10-06 00:00:00 ET · period of report 2023-10-05 · accession 0001661539-23-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-06 | 2023-10-05 | TARS | Trevejo Jose M. | Chief MEDICAL Off | S - Sale | $18.00 | -1,604 | 4,503 | -26% | -$28.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-05 | S | D | 1,604 | $18.00 | 4,503 | D | — | — |